In a report released yesterday, Stephanie Davis from Barclays maintained a Sell rating on Lifestance Health Group (LFST – Research Report), with a price target of $8.00. The company’s shares closed yesterday at $8.71.
According to TipRanks, Davis is an analyst with an average return of -6.7% and a 42.86% success rate. Davis covers the Healthcare sector, focusing on stocks such as Healthequity, Laboratory, and McKesson.
Currently, the analyst consensus on Lifestance Health Group is a Hold with an average price target of $9.00.
See today’s best-performing stocks on TipRanks >>
LFST market cap is currently $3.3B and has a P/E ratio of -17.27.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Lifestance Health Group (LFST) Company Description:
LifeStance Health Group Inc is a providers of virtual and in-person outpatient mental health care for children, adolescents and adults experiencing a variety of mental health conditions. The company delivers personalized, data-driven and comprehensive care to help patients stay healthy and employs over 3,300 psychiatrists, advanced practice nurses, psychologists and therapists.
Read More on LFST:
